0001892688-22-000023.txt : 20220214 0001892688-22-000023.hdr.sgml : 20220214 20220214163724 ACCESSION NUMBER: 0001892688-22-000023 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220214 DATE AS OF CHANGE: 20220214 EFFECTIVENESS DATE: 20220214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lynx1 Capital Management LP CENTRAL INDEX KEY: 0001910456 IRS NUMBER: 851134656 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-22151 FILM NUMBER: 22633286 BUSINESS ADDRESS: STREET 1: 2 RIDGE TOP DRIVE CITY: HUMACAO STATE: PR ZIP: 00791 BUSINESS PHONE: 703-963-7214 MAIL ADDRESS: STREET 1: 2 RIDGE TOP DRIVE CITY: HUMACAO STATE: PR ZIP: 00791 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001910456 XXXXXXXX 12-31-2021 12-31-2021 Lynx1 Capital Management LP
2 RIDGE TOP DRIVE HUMACAO PR 00791
13F HOLDINGS REPORT 028-22151 N
Weston Nichols Chief Investment Officer 703-963-7214 Weston Nichols Humacao PR 02-14-2022 1 10 114610 false 1 0001910444 Lynx1 Capital Advisors LLC
INFORMATION TABLE 2 lynx113fdec2021.xml ALPINE IMMUNE SCIENCES INC COM 02083G100 17478 1261927 SH OTR 1 0 1261927 0 BELLUS HEALTH INC NEW COM NEW 07987C204 16125 2003114 SH OTR 1 0 2003114 0 CYMABAY THERAPEUTICS INC COM 23257D103 4140 1224968 SH OTR 1 0 1224968 0 IMMUNOGEN INC COM 45253H101 15801 2129531 SH OTR 1 0 2129531 0 MERUS N V COM N5749R100 24912 783398 SH OTR 1 0 783398 0 OTONOMY INC COM 68906L105 62 30000 SH OTR 1 0 30000 0 PARDES BIOSCIENCES INC COM 69945Q105 6574 401593 SH OTR 1 0 401593 0 PIERIS PHARMACEUTICALS INC COM 720795103 1449 383266 SH OTR 1 0 383266 0 THESEUS PHARMACEUTICALS INC COM 88369M101 5191 409358 SH OTR 1 0 409358 0 TRAVERE THERAPEUTICS INC COM 89422G107 22878 737061 SH OTR 1 0 737061 0